BioSyent Inc.
BIOYFOTCHealthcare● Active
$9.97
+$0.16(+1.63%)
Market Cap$114040030
P/E Ratio—
52W High$12
52W Low$7.63
BioSyent Inc. (BIOYF) · Income Statement
Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.
FMP · BIOYF · as of 2026-06-09
Financial statements
Revenue · Gross Profit · Net Income
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $43.02M | $35.03M | $31.59M | $27.93M | $28.62M |
| Cost of Revenue | $10.93M | $7.17M | $5.99M | $5.07M | $5.98M |
| Gross Profit | $32.08M | $27.86M | $25.60M | $22.86M | $22.64M |
| Gross Margin %(computed) | 74.59% | 79.52% | 81.03% | 81.85% | 79.10% |
| Operating Expenses | |||||
| R&D Expenses | $0.34M | $0.17M | $0.08M | $0.22M | $0.28M |
| G&A Expenses | $0.00M | $10.79M | $18.01M | $8.86M | $4.58M |
| Total Operating Expenses | $20.78M | $19.10M | $18.13M | $15.95M | $14.39M |
| Operating Income | $11.30M | $8.75M | $7.47M | $6.98M | $8.18M |
| Operating Margin %(computed) | 26.28% | 24.99% | 23.65% | 25.00% | 28.59% |
| Interest Income | $0.81M | $1.09M | $1.13M | $0.53M | $0.14M |
| Interest Expense | $0.05M | $0.06M | $0.07M | $0.08M | $0.09M |
| Income Before Tax | $12.02M | $9.78M | $8.53M | $7.43M | $8.38M |
| Income Tax Expense | $3.02M | $2.51M | $2.07M | $1.97M | $2.10M |
| Net Income | $9.00M | $7.27M | $6.46M | $5.46M | $6.28M |
| Net Margin %(computed) | 20.93% | 20.75% | 20.45% | 19.55% | 21.95% |
| Per Share & EBITDA | |||||
| EPS (Basic) | $0.80 | $0.64 | $0.53 | $0.44 | $0.50 |
| Wtd Avg Shares | 11.26M | 11.37M | 12.17M | 12.30M | 12.69M |
| EBITDA | $12.16M | $10.43M | $7.76M | $7.43M | $8.64M |
| EBITDA Margin %(computed) | 28.26% | 29.78% | 24.58% | 26.62% | 30.19% |
Data source: Financial Modeling Prep · Last updated: 2026-06-09 · CAD · M
Explore more BioSyent Inc. data
About BioSyent Inc. (BIOYF) Income Statement
BioSyent Inc. (BIOYF) income statement data is sourced from SEC Form 10-K and 10-Q filings. For fiscal year 2025, BIOYF reported revenue of $0.04B, gross profit of $0.03B (gross margin 74.59%), and net income of $0.01B — a net profit margin of 20.93%.
Frequently asked questions
BIOYF · 4 questionsBioSyent Inc. (BIOYF) reported revenue of $0.04B for 2025, up 22.8% year-over-year.
BIOYF revenueBIOYF salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-09